blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0617966

EP0617966 - Augmenting fetal hemoglobin by treatment with activin and/or inhibin and a method of in vitro diagnosis [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.11.1996
Database last updated on 19.10.2024
Most recent event   Tooltip01.11.1996Application deemed to be withdrawnpublished on 18.12.1996 [1996/51]
Applicant(s)For all designated states
Perrine, Susan P.
2682 Longview Drive Richmond
California 94806 / US
For all designated states
Albers, Norbert, Dr.
Auf dem Weiler 8
53125 Bonn / DE
[N/P]
Former [1996/37]For all designated states
Perrine, Susan P.
2682 Longview Drive
Richmond, California 94806 / US
For all designated states
Albers, Norbert, Dr.
Auf dem Weiler 8
53125 Bonn / DE
Former [1994/40]For all designated states
Perrine, Susan P.
2682 Longview Drive
Richmond, California 94806 / US
For all designated states
Albers, Norbert
Edwin-Scharff-Ring 67
D-22309 Hamburg / DE
Inventor(s)01 / see applicant
...
[1994/40]
Representative(s)Allard, Susan Joyce, et al
BOULT WADE TENNANT, Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [1994/40]Allard, Susan Joyce, et al
BOULT, WADE & TENNANT 27 Furnival Street
London EC4A 1PQ / GB
Application number, filing date94200748.501.11.1989
[1994/40]
Priority number, dateUS1988026642101.11.1988         Original published format: US 266421
[1994/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0617966
Date:05.10.1994
Language:EN
[1994/40]
Search report(s)(Supplementary) European search report - dispatched on:EP11.08.1994
ClassificationIPC:A61K37/02
[1994/40]
CPC:
G01N33/721 (EP,US); A61K38/22 (EP,US); A61K38/24 (EP,US);
A61P7/00 (EP); G01N33/74 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1994/40]
TitleGerman:Erhöhung des fetalen Hämoglobins durch Behandlung mit Activin und/oder Inhibin sowie eine Methode zur Invitro Diagnostik[1994/40]
English:Augmenting fetal hemoglobin by treatment with activin and/or inhibin and a method of in vitro diagnosis[1994/40]
French:Augmentation de l'hémoglobine fétale par traitement à l'activine et/ou à l'inhibine, ainsi qu'une méthode de diagnostique in-vitro[1994/40]
Examination procedure05.04.1995Examination requested  [1995/22]
01.06.1996Application deemed to be withdrawn, date of legal effect  [1996/51]
01.07.1996Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1996/51]
Parent application(s)   TooltipEP89311297.9  / EP0367590
Fees paidRenewal fee
23.03.1994Renewal fee patent year 03
23.03.1994Renewal fee patent year 04
23.03.1994Renewal fee patent year 05
10.04.1995Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.199406   M06   Fee paid on   10.04.1995
30.11.199507   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]JPS61229826  ;
 [X]EP0220030  (BIOTECH AUSTRALIA PTY LTD [AU]) [X] 6,7,13,15 * claims 1-3,22,23 *;
 [X]WO8805789  (BIOTECH AUSTRALIA PTY LTD [AU], et al) [X] 6,8,9,13,15 * claims 1-17 *;
 [PX]DE3822459  (BPD BIOPHARM DEV LTD [GB]) [PX] 6,8,13,15,16,19 * the whole document *;
 [A]  - O.A. DADA, "Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, LH and FSH in adult males.", CLIN. CHIM. ACTA, (1980), vol. 105, no. 2, doi:doi:10.1016/0009-8981(80)90469-6, pages 269 - 273, XP023400434

DOI:   http://dx.doi.org/10.1016/0009-8981(80)90469-6
 [A]  - G. FRIEDMAN ET AL., "Testicular function in sickle cell disease.", FERTIL. STERIL., (1974), vol. 25, no. 12, pages 1018 - 1021
 [X]  - PATENT ABSTRACTS OF JAPAN, (19870306), vol. 11, no. 75, Database accession no. (C - 408)<2522>, & JP61229826 A 19861014 (MASAO IGARASHI) [X] 6 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.